Gerri S. Hall

4.2k citations
91 papers · 3.1k indexed · h-index 28

Impact in

Papers in

    • Antimicrobial Resistance in Staphylococcus 17
    • Antifungal resistance and susceptibility 14
    • Tuberculosis Research and Epidemiology 8

Gerri S. Hall

89 papers receiving 3.0k citations

Peers

Gerri S. Hall
Comparison fields: 5 of 128
  • Molecular Medicine 551
  • Clinical Biochemistry 731
  • Microbiology 59
  • Endocrinology 376
  • Infectious Diseases 1.3k
Replace Frida Stock with:
Frida Stock United States
Audrey N. Schuetz United States
Tak‐Lun Que China
Barbara Zimmer United States
Audrey Wanger United States
Michel Delmée Belgium
Michael Hombach Switzerland
Scott A. Cunningham United States
Robert Rennie Canada
Robert D. Arbeit United States
Gerri S. Hall relative to Frida Stock United States Frida Stock's profile →
Citations per field
00.5×1.5×1.9×
Frida Stock · 1×
Citations per year

Countries citing papers authored by Gerri S. Hall

Since Specialization
Citations

This map shows the geographic impact of Gerri S. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerri S. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerri S. Hall more than expected).

Fields of papers citing papers by Gerri S. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerri S. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerri S. Hall. The network helps show where Gerri S. Hall may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerri S. Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerri S. Hall Line = papers co-authored together Gerri S. Hall links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 201038
3 200916
4 200922
5 200812
6 200717
7 20066
8 20027
9 20026
10 200119
11
TEMPERATURE AND FOOD ADDITIVES AFFECT GROWTH AND SURVIVAL OF ESCHERICHIA COLI O157:H7 IN POULTRY MEAT
19965
12 199519
13 199410
14 199452
15 19939
16 19939
17 199029
18
Comparative evaluation of the quantum ii api yeast ident and vitek ams ybc system for rapid identification of yeasts not candida albicans
19892
19 198927
20 19898

About Gerri S. Hall

Gerri S. Hall is a scholar working on Microbiology, Infectious Diseases, Clinical Biochemistry, Molecular Medicine and Small Animals, having authored 91 papers that have together received 3.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (17 papers), Bacterial Identification and Susceptibility Testing (15 papers), Antifungal resistance and susceptibility (14 papers), Mycobacterium research and diagnosis (14 papers), Fungal Infections and Studies (13 papers), Infective Endocarditis Diagnosis and Management (10 papers), Infectious Diseases and Mycology (10 papers) and Tuberculosis Research and Epidemiology (8 papers). The work is most often cited by research in Molecular Medicine (551 citations), Clinical Biochemistry (731 citations), Microbiology (59 citations), Endocrinology (376 citations) and Infectious Diseases (1.3k citations). Gerri S. Hall has collaborated with scholars based in United States, Germany and Taiwan. Frequent co-authors include Gary W. Procop, Marion J. Tuohy, Donald A. Wilson, Nabin K. Shrestha, David van Duin, Elizabeth Neuner, Jennifer Sekeres, John L. Frater, John A. Washington and Ana Espinel‐Ingroff. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, American Journal of Clinical Pathology, Archives of Pathology & Laboratory Medicine and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026